Dr. Greg Russell, PhD

Head of Clinical Development, Eyenuk, Inc.

Dr. Greg Russell is Head of Clinical Development at Eyenuk, the company behind EyeArt, the first FDA-cleared autonomous AI system to detect both more-than-mild and vision-threatening diabetic retinopathy. His work centers on the clinical evidence that brings AI eye screening into routine care, helping health systems catch preventable vision loss earlier and at scale, especially among people living with diabetes.